Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the clear-cut winner for ...
The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...
CagriSema is a fixed-dose combination of cagrilintide, a long-acting amylin analogue, and semaglutide, a glucagon-like peptide-1 receptor agonist.
The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
Innovation, artificial intelligence, drug costs and shortages, private equity interests, and more left their mark in ...
FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...
Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...
Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...
In 2024, the most-read articles published in Population Health, Equity & Outcomes (PHEO) highlighted the promise of ...
The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...
Body mass index (BMI) and obesity prevalence declined in the United States in 2023, according to a research letter published ...
Today, the U.S. Food and Drug Administration approved the first generic referencing Victoza (liraglutide injection) 18 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback